News Analysis
The Latest
Misleading Ads About PrEP Are Threatening Progress to End the HIV Epidemic. They Must Be Removed.
Pre-exposure prophylaxis (PrEP) is a vital part of ending HIV, but ads targeting people to join lawsuits are planting needless fears in patients, three leading HIV specialists write.
What Needs to Happen Before California Pharmacies Can Sell PrEP and PEP Without an Initial Prescription
Pharmacists will increasingly play a role in pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) access in California.
Controversy Erupts Around Study on Contraception and HIV Risk
The ECHO trial faces backlash and criticism.
IAS 2019: What to Expect in HIV Science
Six thousand HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.
Researchers Discuss Ethics and Privacy Concerns About the Growing Field of HIV Adherence Monitoring
"A lot of patients want to know, 'Who else is going to see this data?'" said Peter Chai of Fenway Health in Boston.
New Campaign, Toolkit Gets Providers PrEP'd for Women
New York City aims to expand PrEP and PEP access by educating more clinicians that serve women.
CROI 2019: What News to Expect in HIV Science and Policy
TheBodyPro is covering all the latest in HIV science at the biggest annual gathering of HIV researchers in the U.S. Here's a preview of what's to come.
What's Up With PrEP and STIs?
Critics have been warning since the concept of oral PrEP was in its infancy that it would lead to major increases in condomless sex among users and a corresponding dramatic spike in STIs. So far, the data has been inconclusive.